Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

          Reset

          Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
          Muscle Injury, Skeletal/Smooth Muscle disorders Adult or Tissue Stem Cell Personalized cell therapy, Therapeutic Approach UC Davis
          		Clinical Trial, Phase 1 or Phase 1/2
          Cancer, Solid Tumors Adult or Tissue Stem Cell Personalized cell therapy, Therapeutic Approach BioEclipse Therapeutics INC.
          		Clinical Trial, Phase 1 or Phase 1/2
          Heart Disease, Heart failure Embryonic Stem Cell Donor cell therapy, Therapeutic Approach Stanford
          		Clinical Trial, Phase 1 or Phase 1/2
          Brain Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Stanford
          		Clinical Trial, Phase 1 or Phase 1/2
          B cell cancers, Blood Cancer, Cancer, Leukemia, Leukemia, Acute Myeloid (AML) Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
          		Clinical Trial, Phase 1 or Phase 1/2
          Neurological Disorders, Stroke Embryonic Stem Cell Donor cell therapy, Therapeutic Approach Stanford
          		Clinical Trial, Phase 1 or Phase 1/2
          Amyotrophic Lateral Sclerosis, Neurological Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach Cedars-Sinai
          		Clinical Trial, Phase 1 or Phase 1/2
          Brain Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach COH
          		Clinical Trial, Phase 1 or Phase 1/2
          HIV/AIDS, Immune Disease, Infectious Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
          		Clinical Trial, Phase 1 or Phase 1/2
          Neurological Disorders, Parkinson's Disease Vital Research Opportunity Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach Brain Neurotherapy Bio
          		Clinical Trial, Phase 1 or Phase 1/2
          Corneal Damage, Vision Loss Adult or Tissue Stem Cell Personalized cell therapy, Therapeutic Approach UCLA
          		Clinical Trial, Phase 1 or Phase 1/2
          Retinitis Pigmentosa, Vision Loss Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Cedars-Sinai
          		Clinical Trial, Phase 1 or Phase 1/2
          Brain Cancer, Breast Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach COH
          		Clinical Trial, Phase 1 or Phase 1/2
          Cystinosis, Kidney Disease, Kidney Failure, Metabolic Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSD
          		Clinical Trial, Phase 1 or Phase 1/2
          Diabetes, Metabolic Disorders, Type 1 diabetes Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach UCSF
          		Clinical Trial, Phase 1 or Phase 1/2
          Blood Disorders, Severe Combined Immunodeficiency, X-linked (X-SCID) Adult or Tissue Stem Cell Antibody, Biologic, Therapeutic Approach Jasper Therapeutics, Inc.
          		Clinical Trial, Phase 1 or Phase 1/2
          Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
          		Clinical Trial, Phase 1 or Phase 1/2
          Cancer, Lung Cancer, Solid Tumors Adult or Tissue Stem Cell Antibody, Biologic, Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
          		Clinical Trial, Phase 1 or Phase 1/2
          Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Medeor Acquisition Corp.
          		Clinical Trial, Phase 3
          Blood Disorders, Bone Marrow Transplant and Viral Infection Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach CHLA
          		Clinical Trial, Phase 1 or Phase 1/2
          Retinitis Pigmentosa, Vision Loss Other Donor cell therapy, Therapeutic Approach jCyte
          		Clinical Trial, Phase 2
          Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
          		Clinical Trial, Phase 1 or Phase 1/2
          Blood Disorders, Genetic Disorder, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
          		Clinical Trial, Phase 2
          Blood Cancer, Cancer, HIV-related Lymphoma, HIV/AIDS, Infectious Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UC Davis
          		Clinical Trial, Phase 1 or Phase 1/2
          Blood Disorders, Immune Disease, Pediatrics, X-linked Chronic Granulomatous Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
          		Clinical Trial, Phase 1 or Phase 1/2
          Neurological Disorders Gene Therapy (All), Gene Therapy, cell free, Nucleic acid based therapy, Therapeutic Approach Cure Rare Disease
          		IND
          UC Davis
          Heart Disease Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach Rejuvenate Bio
          		IND
          Neurological Disorders Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach Amplo Biotechnology Inc
          		IND
          Heart Disease, Heart failure Antibody, Biologic, Therapeutic Approach UCLA
          		IND
          Neurological Disorders, Spinal Cord Injury Embryonic Stem Cell Donor cell therapy, Therapeutic Approach UCSD
          		IND
          Cancer, Sarcoma, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach CHLA
          		IND
          Blood Cancer, Cancer, Multiple Myeloma Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
          		IND
          Developmental Disorders, Genetic Disorder, Neurological Disorders, Pediatrics Gene Therapy (All), Gene Therapy, cell free, Nucleic acid based therapy, Therapeutic Approach Elpida Therapeutics
          		IND
          Cancer, Ovarian Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach COH
          		IND
          Heart Disease, Heart failure Adult or Tissue Stem Cell, Somatic Cell Biologic, Exosomes based therapy, Therapeutic Approach Cedars-Sinai
          		IND
          Epilepsy, Intellectual Disability, Neurological Disorders Gene Therapy (All), Gene Therapy, cell free, Nucleic acid based therapy, Therapeutic Approach Mahzi Therapeutics
          		IND
          Blood Disorders, Sickle Cell Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UC Davis
          		IND
          Age-related macular degeneration, Vision Loss Embryonic Stem Cell Biologic, Therapeutic Approach USC
          		IND
          Cystic Fibrosis, Respiratory Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Stanford
          		IND
          Bone or Cartilage Disease, Cartilage defect Somatic Cell Donor cell therapy, Therapeutic Approach UC Irvine
          		IND
          Age-related macular degeneration, Vision Loss iPS Cell Personalized cell therapy, Therapeutic Approach UCLA
          		IND
          Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML) Small molecule therapy, Therapeutic Approach Aspera Biomedicines, Inc.
          		IND
          Genetic Disorder, Metabolic Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Rampart Bioscience
          		IND
          Immune Disease Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Ossium Health, Inc.
          		IND
          Breast Cancer, Cancer, Melanoma, Solid Tumors Somatic Cell Donor cell therapy, Therapeutic Approach Calidi Biotherapeutics, Inc.
          		IND
          Neurological Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Personalized cell therapy, Therapeutic Approach UC Davis
          		IND
          Genetic Disorder, Metabolic Disorders, Neurological Disorders, Pediatrics Somatic Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Stanford
          		IND
          Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
          		IND
          Blood Disorders, X-linked Chronic Granulomatous Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach ImmunoVec
          		Clinical Trial, Phase 1 or Phase 1/2
          1 2 3 4 5
          Displaying 151 – 200 of 248